Literature DB >> 146053

Cytotoxic activity of lymphocytes. VII. cellular origin of alpha-lymphotoxin.

K Yano, Z J Lucas.   

Abstract

To detect the cellular origins of alpha-lymphotoxin (alpha-LT), we cultured various subpopulations of human blood lymphocytes separated by erythrocyte-rosetting techniques with various mitogens. T cell-enriched subpopulations responded to PHA by increased 3H-thymidine uptake into DNA and large amounts of alpha-LT production. SPL and Con A-Sepharose stimulated DNA synthesis in T cell-enriched cultures if the macrophage content was greater than 1.5%; however, alpha-LT production was not induced by these two mitogens even when reconstituted with 10% macrophages. B and/or null cell-enriched populations severely depleted of T cells (less than 0.7% did not respond to PHA, SPL, or Con A-Sepharose. However, reconstitution to 5 or more percent in E-RFC allowed all three mitogens to stimulate DNA synthesis and alpha-LT production. The LT made by all cell populations 5 and 7 days after stimulation were equally neutralized by a heterologous antiserum to alpha-LT. These results show that human T and B and/or null cells, when appropriately stimulated, can produce alpha-LT.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 146053

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  Production of mouse lymphotoxin by phytohemagglutinin-stimulated spleen cells requires two cell fractions.

Authors:  R R Aksamit; E J Leonard
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

2.  Effect of soluble products from lectin-stimulated lymphocytes on the growth, adhesiveness, and glycosaminoglycan synthesis of cultured synovial fibroblastic cells.

Authors:  T P Anastassiades; A Wood
Journal:  J Clin Invest       Date:  1981-09       Impact factor: 14.808

3.  Induction of lymphotoxin-alpha by interleukin-12 p40 homodimer, the so-called biologically inactive molecule, but not IL-12 p70.

Authors:  Malabendu Jana; Kalipada Pahan
Journal:  Immunology       Date:  2008-11-14       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.